n.a. (MHS)

70.30
NYSE
Prev Close 70.30
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NYSE
Div & Yield N.A. (N.A)

Latest News

J&J Taps Bayer Exec For New Post Over 3 Divisions

J&J Taps Bayer Exec For New Post Over 3 Divisions

Johnson & Johnson hiring Bayer exec for new post over consumer health, manufacturing and IT

Link: I'm a Buyer of Bristol Myers in Low $30s

Link: I'm a Buyer of Bristol Myers in Low $30s

Stephanie Link, director of research at TheStreet, says the move in Bristol Myers' stock from the suspension of a Hepatitis C compound has been overdone and sees value in the stock.

Business Highlights

Business Highlights

Business Highlights

Express Scripts and CVS = Real Winners in Walgreen Deal

Express Scripts and CVS = Real Winners in Walgreen Deal

Stephanie Link, director of research at TheStreet, says CVS and Express Scripts are the real winners in Express Scripts' PBM agreement with Walgreen, and is buying CVS on today's pull back.

CVS Has the Right Prescription

CVS Has the Right Prescription

Stephanie Link, director of research at TheStreet, likes CVS for more than the market share they are gaining from Walgreen.

SXC Health Buys Catalyst for $4.4B as Pill Pushers Consolidate (Update 1)

SXC Health Buys Catalyst for $4.4B as Pill Pushers Consolidate (Update 1)

SXC Health Solutions' acquisition of Catalyst Health Solutions adds to consolidation in the pharmacy benefits space.

5 Most-Popular Stocks for Billionaires

5 Most-Popular Stocks for Billionaires

Before you sacrifice a chunk of your cash to hedge fund managers' fees, try investing in their favorite picks.

US Futures Mixed Before Business Orders Report

US Futures Mixed Before Business Orders Report

US stocks fall after Federal Reserve policy minutes reveal dimmer outlook for jobs, growth

Business Highlights

Business Highlights

Business Highlights

Express Scripts, Medco Deal Gets FTC Approval (Update 1)

Express Scripts, Medco Deal Gets FTC Approval (Update 1)

The FTC has approved a $29 billion acquisition by Express Scripts Deal for Medco Health Solutions.

Tyco, Medco: S&P Gainers

Tyco, Medco: S&P Gainers

These stocks were the best performers in the S&P 500 on Wednesday.

Medco, Toll Brothers, Tyco Hit 52-Week Highs

Medco, Toll Brothers, Tyco Hit 52-Week Highs

These stocks reach 52-week highs on Wednesday.

Medco Health Reaches New 52-Week High (MHS)

Medco Health Reaches New 52-Week High (MHS)

Medco Health Solutions (NYSE:MHS) hit a new 52-week high Wednesday as it is currently trading at $72.29, above its previous 52-week high of $70.97 with 7.8 million shares traded as of 9:35 a.m. ET. Average volume has been 3.3 million shares over the past 30 days.

Patients Who Know Their Gene Test Results Are More Likely To Regularly Take And Remain On Statins, Study At ACC Shows

Patients Who Know Their Gene Test Results Are More Likely To Regularly Take And Remain On Statins, Study At ACC Shows

Study provides first evidence that pharmacogenetic testing can improve patient adherence to prescription drug therapy

'Mad Money Lightning Round: Freeport-McMoRan Will Surprise

'Mad Money Lightning Round: Freeport-McMoRan Will Surprise

Cramer says people will be surprised by the demand for copper.

The Mental Health Gender Gap: Women Far Exceed Men In Their Use Of Psychotropic Medications As Utilization Increases Among Both Sexes

The Mental Health Gender Gap: Women Far Exceed Men In Their Use Of Psychotropic Medications As Utilization Increases Among Both Sexes

More than One-in-Four Women take Medication to Treat a Mental Health Condition

More Is Sometimes Less: Women Are Prescribed A Greater Number Of Medications Than Men But Take Less Of The Drugs They Need

More Is Sometimes Less: Women Are Prescribed A Greater Number Of Medications Than Men But Take Less Of The Drugs They Need

New Medco study shows that, despite higher prescription rate, women fare worse in 25 out of 25 clinical measurements

Medco Study Finds Many Patients On Newer Oncology Treatments Are At Risk For Drug Interactions

Medco Study Finds Many Patients On Newer Oncology Treatments Are At Risk For Drug Interactions

Oral Cancer Drugs Need Added Monitoring to Prevent Safety Risks, Impaired Effectiveness

Medco To Present Results Of National Study On Effect Of Genetic Testing On Patient Medication Adherence At The American College Of Cardiology 61st Annual Scientific Session And Expo

Medco To Present Results Of National Study On Effect Of Genetic Testing On Patient Medication Adherence At The American College Of Cardiology 61st Annual Scientific Session And Expo

New data presentation from the first prospective study to explore the influence of pharmacogenetic testing on medication adherence and persistence

Medco Health Rises On Unusually High Volume (MHS)

Medco Health Rises On Unusually High Volume (MHS)

Medco Health Solutions (NYSE:MHS) is trading at unusually high volume Tuesday with 13.4 million shares changing hands. It is currently at 4.1 times its average daily volume and trading up $2.13 (+3.1%).

Stocks to Watch: Midas, Urban Outfitters (update 1)

Stocks to Watch: Midas, Urban Outfitters (update 1)

Midas shares are surging in premarket trading Tuesday after TBC said it would buy the company for about $310 million.

5 Things You Need to Know Before the Stock Market Opens

5 Things You Need to Know Before the Stock Market Opens

A policy statement from the Fed and February retail sales are on tap Tuesday.

3 Stocks Reach 52-Week Highs: MAT, CVS, MHS

3 Stocks Reach 52-Week Highs: MAT, CVS, MHS

These stocks hit 52-week highs on Friday.

Medco Health Reaches New 52-Week High (MHS)

Medco Health Reaches New 52-Week High (MHS)

Medco Health Solutions (NYSE:MHS) hit a new 52-week high Friday as it is currently trading at $69.61, above its previous 52-week high of $69.10 with five million shares traded as of 12:50 p.m. ET. Average volume has been 3.3 million shares over the past 30 days.

8 Stocks Billionaire John Paulson Loves

8 Stocks Billionaire John Paulson Loves

Here's a look at eight stocks that Paulson & Co. bought in the fourth quarter.

Medco Tops Industry On Fortune's List Of 'World's Most Admired Companies' For Fifth Consecutive Year

Medco Tops Industry On Fortune's List Of 'World's Most Admired Companies' For Fifth Consecutive Year

Medco listed No. 1 in "Health Care: Pharmacy and Other Services" category by earning the highest rankings for innovation, people management, social responsibility, quality of management, quality of products/services